Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Not applicable Interventional Accepts healthy volunteers

A Clinical Trial to Evaluate the Effects of a Supplement on Appetite, Gut Health, and Blood Sugar

ClinicalTrials.gov ID: NCT07946978

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT07946978. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 19, 2026, 2:19 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study evaluates the effects of the Etta Vita GLP-1 supplement on appetite, gut health, and blood sugar over a 12-week period. Thirty participants with a BMI of 25 or greater and experiencing at least two of the following issues - food cravings, poor appetite control, irregular bowel movements, bloating, or gut issues - will use the test product daily. The trial is a single-arm, open-label study in which all participants take two capsules of the supplement each morning, no more than 15 minutes before their first meal. Participants complete questionnaires at Baseline, Week 4, Week 8, and Week 12, and attend their local clinic for blood tests (HbA1c, Glucose, and Leptin) at Baseline and Week 12.

Study identification

NCT ID
NCT07946978
Recruitment status
Completed
Study type
Interventional
Phase
Not applicable
Lead sponsor
Etta Vita
Industry
Enrollment
30 participants

Conditions and interventions

Eligibility (public fields only)

Age range
21 Years to 60 Years
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 1, 2026 (Actual)
Primary completion
Aug 30, 2026 (Actual)
Completion
Aug 30, 2026 (Actual)
Last update posted
Nov 18, 2026

2026

United States locations

U.S. sites
1
U.S. states
1
U.S. cities
1
Facility City State ZIP Site status
Citruslabs Las Vegas Nevada 89101 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07946978, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 18, 2026 · Synced Nov 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.